A systematic review of different substance injection and dry needling for treatment of temporomandibular myofascial pain


      Temporomandibular myofascial pain presents a major challenge in the diagnosis of temporomandibular disorders (TMD). Due to the characteristics of this condition, intramuscular injection procedures are often needed for adequate control of symptoms and treatment. Thus, the aim of this systematic review was to evaluate the effectiveness of dry needling and injection with different substances in temporomandibular myofascial pain. Electronic databases PubMed, EMBASE, CENTRAL/Cochrane, Lilacs, Scopus, Web of Science and CAPES Catalog of Dissertations and Theses were searched for randomized clinical trials until January 2018. Manual search was performed in relevant journals and in the references/citations of the included studies. The selection of studies was carried out by two independent reviewers according to eligibility criteria. From 7128 eligible studies, 137 were selected for full-text analysis and 18 were included. Due to the heterogeneity of the primary studies it was not possible to perform a meta-analysis. The narrative analysis of the results showed that most of the studies had methodological limitations and biases that compromised the quality of the findings. Dry needling and local anaesthesic injections seem promising, but there is a need to conduct further randomized clinical trials, with larger samples and longer follow-up times, to evaluate the real effectiveness of the technique and evaluated substances.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Poveda-Roda R.
        • Bagan J.V.
        • Sanchis J.M.
        • Carbonell E.
        Temporomandibulardisorder: a case control study.
        Med Oral Patol Oral Cir Bucal. 2012; 17: e794-800
        • Dao T.T.
        • LeResche L.
        Gender differences in pain.
        J Orofac Pain. 2000; 14: 169-184
        • Macfarlane T.V.
        • Blinkhorn A.S.
        • Davies R.M.
        • Kincey J.
        • Worthington H.V.
        Oro-facial pain in the community: prevalence and associated impact.
        Community Dent Oral Epidemiol. 2002; 30: 52-60
        • Janal M.N.
        • Raphael K.G.
        • Nayak S.
        • Klausner J.
        Prevalence of myofascial temporomandibular disorder in US community women.
        J Oral Rehabil. 2008; 35: 801-809
        • Simons D.G.
        • Travell J.G.
        • Simons L.S.
        Myofascial pain and dysfunction: the trigger point manual; vol. 1 upper half of body.
        2nd ed. Williams & Wilkins, Baltimore1999
        • Laskin D.M.
        Etiology of the pain-dysfunction syndrome.
        Am J Dent Assoc. 1969; 79: 147-153
        • Laskin D.M.
        Temporomandibular Joint Pain.
        in: Ruddy S. Harris E.D. Sledge C.B. Kelly’s textbook of Rheumatology. WB Saunders Co, Philadelphia2001: 557-567
        • McMillan A.S.
        • Nolan A.
        • Kelly P.J.
        The efficacy of dry needling and procaine in the treatment of myofascial pain in the jaw muscles.
        J Orofac Pain. 1997; 11: 307-314
        • Porta M.
        A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
        Pain. 2000; 85: 101-105
        • Graboski C.L.
        • Gray D.S.
        • Burnham R.S.
        Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
        Pain. 2005; 118: 170-175
        • Ho K.Y.
        • Tan K.H.
        Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
        Eur J Pain. 2007; 11: 519-527
        • Soares A.
        • Andriolo R.B.
        • Atallah A.N.
        • da Silva E.M.
        Botulinum toxin for myofascial pain syndromes in adults.
        Cochrane Database Syst Rev. 2014; (The Cochrane Library)CD007533
        • Kietrys D.M.
        • Palombaro K.M.
        • Azzaretto E.
        • Hubler R.
        • Schaller B.
        • Schlussel J.M.
        • Thucker M.
        Effectiveness of dry needling for upper-quarter myofascial pain: a systematic review and meta-analysis.
        J Orthop Sports Phys Ther. 2013; 43: 620-634
        • Ernberg M.
        • Hedenberg-Magnusson B.
        • List T.
        • Svensson P.
        Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study.
        Pain. 2011; 152: 1988-1996
        • Fernández-Carnero J.
        • La Touche R.
        • Ortega-Santiago R.
        • Galan-del-Rio F.
        • Pesquera J.
        • Ge H.Y.
        • Fernández-de-Las-Peñas C.
        Short-term effects of dry needling of active myofascial trigger points in the masseter muscle in patients with temporomandibular disorders.
        J Orofac Pain. 2010; 24: 106-112
        • Dıraçoglu D.
        • Vural M.
        • Karan A.
        • Aksoy C.
        Effectiveness of dry needling for the treatment of temporomandibular myofascial pain: A double-blind, randomized, placebo controlled study.
        J Back Musculoskelet Rehabil. 2012; 25: 285-290
        • Systematic Reviews Centre for Reviews and Dissemination (CRD)
        CRD’s Guidance for Undertaking Reviews Health Care.
        3rd ed. York Publishing Services Ltd, York, UK2009
        • Machado E.
        • Machado P.
        • Kaizer O.B.
        Evaluation of different substances injections or dry needling in temporomandibular myofascial pain: a systematic review. PROSPERO 2014.
        2014 (CRD42014014141)
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        • PRISMA Group
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        BMJ. 2009; 339: b2535
        • Higgins J.P.
        • Green S.
        Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011].
        The Cochrane Collaboration, 2011 (Accessed on 11/05/2014 at:
        • Higgins J.P.
        • Altman D.G.
        • Gøtzsche P.C.
        • Jüni P.
        • Moher D.
        • Oxman A.D.
        • Savovic J.
        • Schulz K.F.
        • Weeks L.
        • Sterne J.A.
        • Cochrane Bias Methods Group
        • Cochrane Statistical Methods Group
        The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.
        BMJ. 2011; 18: d5928
        • Higgins J.P.
        • Thompson S.G.
        Quantifying heterogeneity in a meta-analysis.
        Stat Med. 2002; 21: 1539-1558
        • Nixdorf D.R.
        • Heo G.
        • Major P.W.
        Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain.
        Pain. 2002; 99: 465-473
        • Von Lindern J.J.
        • Niederhagen B.
        • Bergé S.
        • Appel T.
        Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
        J Oral Maxillofac Surg. 2003; 61: 774-778
        • Christidis N.
        • Nilsson A.
        • Kopp S.
        • Ernberg M.
        Intramuscular injection of granisetron into the masseter muscle increases the pressure pain threshold in healthy participants and patients with localized myalgia.
        Clin J Pain. 2007; 23: 467-472
        • Castrillon E.E.
        • Cairns B.E.
        • Ernberg M.
        • Wang K.
        • Sessle B.J.
        • Arendt-Nielsen L.
        • Svensson P.
        Effect of peripheral NMDA receptor blockade with ketamine on chronic myofascial pain in temporomandibular disorder patients: a randomized, double-blinded, placebo-controlled Trial.
        J Orofac Pain. 2008; 22: 122-130
        • Guarda-Nardini L.
        • Manfredini D.
        • Salamone M.
        • Salmaso L.
        • Tonello S.
        • Ferronato G.
        Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
        Cranio. 2008; 26: 126-135
        • Kurtoglu C.
        • Gur O.H.
        • Kurkcu M.
        • Sertdemir Y.
        • Guler-Uysal F.
        • Uysal H.
        Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
        J Oral Maxillofac Surg. 2008; 66: 1644-1651
        • Venâncio RdeA
        • Alencar F.G.
        • Zamperini C.
        Different substances and dry-needling injections in patients with myofascial pain and headaches.
        Cranio. 2008; 26: 96-103
        • Venancio RdeA
        • Alencar F.G.
        • Zamperini C.
        Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches.
        Cranio. 2009; 27: 46-53
        • Guarda-Nardini L.
        • Stecco A.
        • Stecco C.
        • Masiero S.
        • Manfredini D.
        Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique.
        Cranio. 2012; 30: 95-102
        • Silva R.O.F.
        • Conti P.C.R.
        • Araújo C.R.P.
        • Silva R.S.
        Evaluation of dry needling and 0.5% lidocaine injection therapies in myofascial pain trigger points in masticatory muscles.
        Dental Press J Orthod. 2012; 17: 113-118
        • Uemoto L.
        • Garcia M.A.
        • Gouvêa C.V.
        • Vilella O.V.
        • Alfaya T.A.
        Laser therapy and needling in myofascial trigger point deactivation.
        J Oral Sci. 2013; 55: 175-181
        • Gonzalez-Perez L.M.
        • Infante-Cossio P.
        • Granados-Nunez M.
        • Urresti-Lopez F.J.
        • Lopez-Martos R.
        • Ruiz-Canela-Mendez P.
        Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction.
        Med Oral Patol Oral Cir Bucal. 2015; 20: e326-33
        • Christidis N.
        • Omrani S.
        • Fredriksson L.
        • Gjelset M.
        • Louca S.
        • Hedenberg-Magnusson B.
        • Ernberg M.
        Repeated tender point injections of granisetron alleviate chronic myofascial pain—a randomized, controlled, double-blinded trial.
        J Headache Pain. 2015; 16: 104
        • De Carli B.M.
        • Magro A.K.
        • Souza-Silva B.N.
        • Matos Fde S.
        • De Carli J.P.
        • Paranhos L.R.
        • Magro E.D.
        The effect of laser and botulinum toxin in the treatment of myofascial pain and mouth opening: A randomized clinical trial.
        J Photochem Photobiol B. 2016; 159: 120-123
        • Chen J.T.
        • Chung K.C.
        • Hou C.R.
        • Kuan T.S.
        • Chen S.M.
        • Hong C.Z.
        Inhibitory effect of dry needling on the spontaneous electrical activity recorded from myofascial trigger spots of rabbitskeletal muscle.
        Am J Phys Med Rehabil. 2001; 80: 729-735
        • Hong C.Z.
        Lidocaine injection versus dry needling to myofascial trigger point: The importance of the local twitch responce.
        Am J Phys Med Rehabil. 1994; 73: 256-263